Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C21H24N4O2 |
| Molecular Weight | 364.4409 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
O=C1NC2=C(C=CC=C2)C(=O)N1CCCN3CCN(CC3)C4=CC=CC=C4
InChI
InChIKey=WPKPLSFHHBBLRY-UHFFFAOYSA-N
InChI=1S/C21H24N4O2/c26-20-18-9-4-5-10-19(18)22-21(27)25(20)12-6-11-23-13-15-24(16-14-23)17-7-2-1-3-8-17/h1-5,7-10H,6,11-16H2,(H,22,27)
| Molecular Formula | C21H24N4O2 |
| Molecular Weight | 364.4409 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Pelanserin is an antagonist of the serotonin 5-HT2 receptor and blocks alpha 1-adrenoceptor. Experiments on dogs have revealed that pelanserin showed adequate pharmacokinetic and pharmacodynamics profiles as an antihypertensive agent that is why the drug possessed potential therapeutic usefulness in the treatment of hypertension. Pelanserin was undergoing phase II clinical trials by Cinvestav in Mexico; however, these studied were discontinued.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL2095200 |
|||
Target ID: CHEMBL2094251 Sources: https://www.ncbi.nlm.nih.gov/pubmed/7493607 |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Carbopol 934-Sodium Alginate-Gelatin Mucoadhesive Ondansetron Tablets for Buccal Delivery: Effect of pH Modifiers. | 2010-07 |
|
| Influence of Organic Acids on Diltiazem HCl Release Kinetics from Hydroxypropyl Methyl Cellulose Matrix Tablets. | 2010-07 |
|
| Alkylation of 2,4-(1H,3H)-quinazolinediones with dialkyl carbonates under microwave irradiations. | 2009-05-20 |
|
| Mechanism of the antihypertensive effect of TR2515, a potent serotonin antagonist. | 1984 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:05:58 GMT 2025
by
admin
on
Mon Mar 31 18:05:58 GMT 2025
|
| Record UNII |
6SNR96E409
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C66885
Created by
admin on Mon Mar 31 18:05:58 GMT 2025 , Edited by admin on Mon Mar 31 18:05:58 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
100000083026
Created by
admin on Mon Mar 31 18:05:58 GMT 2025 , Edited by admin on Mon Mar 31 18:05:58 GMT 2025
|
PRIMARY | |||
|
DTXSID60176578
Created by
admin on Mon Mar 31 18:05:58 GMT 2025 , Edited by admin on Mon Mar 31 18:05:58 GMT 2025
|
PRIMARY | |||
|
65435
Created by
admin on Mon Mar 31 18:05:58 GMT 2025 , Edited by admin on Mon Mar 31 18:05:58 GMT 2025
|
PRIMARY | |||
|
C76965
Created by
admin on Mon Mar 31 18:05:58 GMT 2025 , Edited by admin on Mon Mar 31 18:05:58 GMT 2025
|
PRIMARY | |||
|
2208-51-7
Created by
admin on Mon Mar 31 18:05:58 GMT 2025 , Edited by admin on Mon Mar 31 18:05:58 GMT 2025
|
PRIMARY | |||
|
6143
Created by
admin on Mon Mar 31 18:05:58 GMT 2025 , Edited by admin on Mon Mar 31 18:05:58 GMT 2025
|
PRIMARY | |||
|
SUB09648MIG
Created by
admin on Mon Mar 31 18:05:58 GMT 2025 , Edited by admin on Mon Mar 31 18:05:58 GMT 2025
|
PRIMARY | |||
|
Pelanserin
Created by
admin on Mon Mar 31 18:05:58 GMT 2025 , Edited by admin on Mon Mar 31 18:05:58 GMT 2025
|
PRIMARY | |||
|
6SNR96E409
Created by
admin on Mon Mar 31 18:05:58 GMT 2025 , Edited by admin on Mon Mar 31 18:05:58 GMT 2025
|
PRIMARY | |||
|
C043157
Created by
admin on Mon Mar 31 18:05:58 GMT 2025 , Edited by admin on Mon Mar 31 18:05:58 GMT 2025
|
PRIMARY | |||
|
CHEMBL2110706
Created by
admin on Mon Mar 31 18:05:58 GMT 2025 , Edited by admin on Mon Mar 31 18:05:58 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |